Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "CompassHER2 RD Trial - Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients With Residual HER2+ Invasive BC"
By
Insights from 2023 SABCS
FEATURING
Ciara O'Sullivan
By
Insights from 2023 SABCS
FEATURING
Ciara O'Sullivan
304 views
December 15, 2023
Comments 0
Login to view comments.
Click here to Login
Videos